Atrial Fibrillation
📧 Sign up to get email alerts when something new happens for Atrial Fibrillation.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2007-03-20Clinical Trial Update: Silent Cerebrovascular Lesion and Cognitive Decline Prevention by Cholesterol Lowering in Elderly AF Patients [Phase 4]
Phase 4 trial update assessing whether cholesterol-lowering therapy can prevent silent cerebrovascular lesions and cognitive decline in elde…
-
FDA approval · 2007-03-07FDA Approved: AMIODARONE HYDROCHLORIDE — Supplemental Application (Dr. Reddy's Labratories Inc.)
The FDA approved a supplemental application for amiodarone hydrochloride from Dr. Reddy's Laboratories Inc., enabling the generic product's …
-
FDA approval · 2007-03-01FDA Approved: SOTALOL HYDROCHLORIDE — Supplemental Application (Oxford Pharmaceuticals, LLC)
The FDA approved a supplemental application for Sotalol Hydrochloride (Oxford Pharmaceuticals, LLC), updating an existing approved product.
-
CLINICAL_TRIALS trial_result · 2007-03-01Clinical Trial Update: Carvedilol Versus Metoprolol for the Prevention of Atrial Fibrillation After Off-Pump Coronary Bypass Surgery [NA]
A completed clinical trial in Japan comparing carvedilol versus metoprolol for prevention of atrial fibrillation after off-pump coronary art…
-
FDA approval · 2007-02-08FDA Approved: DISOPYRAMIDE PHOSPHATE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for disopyramide phosphate from Teva Pharmaceuticals USA, Inc., indicating an approved update to…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2007-02-07FDA Approved: SOTALOL HYDROCHLORIDE — Original Application (Aurobindo Pharma Limited)
The FDA approved the original application for sotalol hydrochloride (generic) from Aurobindo Pharma Limited, authorizing its marketing as a …
-
CLINICAL_TRIALS trial_result · 2007-01-31Clinical Trial Update: Assessment of Cardioversion Using Transesophageal Echocardiography II (ACUTE II) [Phase 4]
Phase 4 ACUTE II trial evaluating cardioversion using transesophageal echocardiography in atrial fibrillation has completed.
-
FDA approval · 2007-01-19FDA Approved: DIGOXIN — Supplemental Application (Amneal Pharmaceuticals NY LLC)
FDA approved a supplemental application for Digoxin (DIGOXIN) from Amneal Pharmaceuticals NY LLC.
-
CLINICAL_TRIALS trial_result · 2007-01-04Clinical Trial Update: Candesartan in the Prevention of Relapsing Atrial Fibrillation [Phase 3]
A Phase 3 trial evaluating candesartan for prevention of relapsing atrial fibrillation has completed.
-
FDA approval · 2006-12-26FDA Approved: SOTALOL HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved Teva Pharmaceuticals USA, Inc.'s supplemental application for sotalol hydrochloride, a generic antiarrhythmic, under the AN…
-
CLINICAL_TRIALS research · 2006-12-18Clinical Trial Update: Investigation of Genetic Risk of Atrial Fibrillation
Clinical trial update investigating genetic risk factors for atrial fibrillation; status not disclosed.
-
CLINICAL_TRIALS research · 2006-12-13Clinical Trial Update: Studies of the Prevention of Atrial Fibrillation by ALA [Phase 2]
Phase 2 trial investigating whether alpha-linolenic acid (ALA) in the diet can prevent atrial fibrillation; current status is not disclosed.
-
CLINICAL_TRIALS trial_result · 2006-12-12Clinical Trial Update: Arrhythmia Prevention With an Alpha-Linolenic Enriched Diet [Phase 2]
Phase 2 trial assessing whether an alpha-linolenic acid-enriched diet can prevent arrhythmias in atrial fibrillation patients has completed.
-
FDA approval · 2006-12-04FDA Approved: CARTIA XT — Supplemental Application (Actavis Pharma, Inc.)
FDA approved a supplemental application for CARTIA XT (diltiazem hydrochloride) submitted by Actavis Pharma, Inc., authorizing changes to th…
-
CLINICAL_TRIALS trial_result · 2006-10-20Clinical Trial Update: Pacing of the Atria in Sick Sinus Syndrome Trial Preventive Strategies for Atrial Fibrillation [Phase 4]
Phase 4 trial evaluating atrial pacing in sick sinus syndrome to prevent atrial fibrillation has completed.
-
CLINICAL_TRIALS research · 2006-10-18Clinical Trial Update: Arrhythmia Restart Prevention and RatE STabilization in Atrial Fibrillation [Phase 4]
Phase 4 clinical trial update sponsored by Vitatron France evaluating arrhythmia restart prevention and rate stabilization in atrial fibrill…
-
EMA withdrawal · 2006-09-08EMA Application withdrawn: Multaq (dronedarone) — Sanofi-Aventis
EMA withdrew the application for Multaq (dronedarone) for atrial fibrillation/flutter.
-
FDA approval · 2006-07-05FDA Approved: WARFARIN SODIUM — Original Application (Teva Pharmaceuticals USA, Inc.)
FDA approves Teva's Warfarin Sodium generic under an Original Application (ANDA) for this oral anticoagulant.
-
CLINICAL_TRIALS trial_result · 2006-05-05Clinical Trial Update: Amiodarone to Prevent Post-Operative Arrhythmias [Phase 3]
Completion of a Phase 3 trial evaluating amiodarone to prevent post-operative atrial fibrillation.
-
FDA approval · 2006-05-05FDA Approved: JANTOVEN — Supplemental Application (Upsher-Smith Laboratories, LLC)
FDA approved a supplemental application for JANTOVEN (warfarin sodium) from Upsher-Smith Laboratories, LLC.
-
CLINICAL_TRIALS trial_result · 2006-05-05Clinical Trial Update: Use of Radiofrequency Ablation to Eliminate Continuous Atrial Fibrillation in Patients Undergoing Mitral Valve Surgery [NA]
Clinical trial assessing the use of radiofrequency ablation to eliminate continuous atrial fibrillation in patients undergoing mitral valve …
-
FDA approval · 2006-05-04FDA Approved: PROPAFENONE HYDROCHLORIDE — Supplemental Application (Strides Pharma Science Limited)
The FDA approved a supplemental application for Propafenone hydrochloride from Strides Pharma Science Limited, authorizing a generic Propafe…